Induction for CV patient Flashcards

1
Q

Milrinone MOA

A

phosphodiesterase 3 inhibitor; prevent the breakdown of cAMP

Causes positive inotropic action and vasodilation without producing tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Milrinone dosing

A

start infusion at 0.375 mcg/min up to .75 mcg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dobutamine MOA

A

synthetic sympathomimetic amine

Primarily a beta 1 agonist with some B2 effects

Increases: inotropy, cardiac output  BP may slightly increase or remain the same

Decreases: SVR due to peripheral vasodilation; pulmonary artery pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dobutamine dosing

A

Dosing: 0.5-20 mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Norepi causes increased _______ d/t increase in ________BP.

A

-coronary artery perfusion
-diastolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Nitro MOA

A

direct vasodilator – venous&raquo_space; arterial; caused by an induced increase of vascular nitric oxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Nitro concentration dosing

A

nitro “lite” vials obtained from pharmacy come 40 mcg/mL in a 10 mL vial  dose in increments of 40 mcg at a time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nitro infusion dosing

A

is 400 mcg/mL in a 250 mL bottle  infusion rate is typically started at 5 mcg/min in heart room

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Esmolol MOA and metabolism

A

beta 1 selective antagonist

Unique metabolism: nonspecific plasma esterases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Esmolol uses and onset/side effects

A

Has an extremely quick (2 min or less) onset and short half-life  useful to transiently treat elevated HR without carrying lasting effects that may cause subsequent low BP

Often used alongside induction agents prevent an increase in HR during laryngoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Esmolol concentration

A

10 mg/mL in a 10 mL vial  administer in increments of 10-30 mg at a time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Vasopressin MOA

A

endogenous hormone produced in the hypothalamus, stored in posterior pituitary gland; release is stimulated by increased osmolality and hypovolemia
Aka ADH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vasopressin dosing

A

Dosing: comes in vials 20 units/mL  mix one mL with 19 mL NS for a concentration of 1 unit/mL  dose in increments of 1 unit at a time
Infusion dose: 0.04 units/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Epi “heavy”

A

Epi “heavy” 100 mcg/mL – mix 1 mL vial of epi in 9 mL of NS dilutent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Epi “light”

A

” 10 mcg/ml- mix 1 mL of epi “heavy” mixture into 9 mL of NS dilutent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ephedrine MOA

A

synthetic noncatecholamine sympathomimetic
Stimulates Alpha and Beta receptors directly
INDIRECTLY causes a release of endogenous catecholamines (baby epi)

16
Q

Ephedrine Dosing

A

comes in vials of 50 mg/mL  mix 1 mL of ephedrine with 9 mL of NS for a concentration of 5 mg/mL – dose in 5-10 mg increments IV

Can see tachyphylaxis with subsequent dosing due to depletion of catecholamine stores

17
Q

Phenylephrine Infusion dosing

A

start infusion at 0.02 mcg/kg/min

usually comes 20 mg/250 mL (peripheral strength concentration – a heavier concentration may be used via central line in ICU so always check the bag!)

18
Q

Precedex for CABG

A

no loading dose used – often just as an adjunct sedation for time on bypass and transport to ICU at a drip rate of 0.4 mcg/kg/hr